Thrombelastographic evaluation of coagulation in transurethral prostatectomy.
OBJECTIVE
To assess the changes in overall coagulation status and define the degree of systemic fibrinolysis occurring in patients undergoing transurethral prostatectomy (TURP).


METHODS
Thirty patients undergoing TURP, 23 for benign prostatic hyperplasia and seven for prostatic carcinoma, were studied prospectively. Serial venous blood samples were taken using the two-syringe technique. Samples were taken before, during and at intervals up to 72 h and 10-14 days after surgery. Thrombelastography (TEG) was performed on native whole blood samples. Peri-operative blood loss was assessed, until the catheter was removed, by photometric estimation of the haemoglobin content of the irrigant fluid and the measurement of clot volume.


RESULTS
There was no evidence of fibrinolysis (TEG Percentage Clot Lysis Ly60 > 15%) in any patient over the whole peri-operative period. There was a significant change in the mean TEG variables towards hypercoagulation from 3 h until 10-14 days postoperatively, compared with the pre-operative values (P < 0.05). There was a significant correlation between blood loss and clot volume.


CONCLUSIONS
These results question the role of systemic fibrinolysis in primary and secondary haemorrhage following TURP and thus the rationale of using antifibrinolytics in these patients. The persistent hypercoagulable state post-operatively indicates a possible role of hypercoagulability in clot retention.
Bell
C R
CR
Department of Urology, Royal Free Hospital and School of Medicine, London, UK.
Cox
D J
DJ
Murdock
P J
PJ
Sullivan
M E
ME
Pasi
K J
KJ
Morgan
R J
RJ
D001777:Blood Coagulation / Q000502:physiology; D016063:Blood Loss, Surgical; D005342:Fibrinolysis / Q000502:physiology; D006801:Humans; D008297:Male; D010976:Platelet Count; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood*